Concepedia

James B. Aggen

JB

Statistics

Publications

21

Citations

1.4K

H-Index

18

Active since

1996

Affiliations

University of California, Irvine(Current)

Revolution Medicines (United States)

Université de Montréal

Theravance Biopharma (United States)

Superior Court of California

James B. Aggen is an author at University of California, Irvine specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1996–2025

21

Publications

21

Congener-Independent Immunoassay for Microcystins and Nodularins

W Fischer, Ian Garthwaite, Christopher O. Miles et al. · Environmental Science & Technology · 2001 · 263 citations · Full text

Pharmacy, Microbiology, Toxicology +15

Synthesis and Spectrum of the Neoglycoside ACHN-490

James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum et al. · Antimicrobial Agents and Chemotherapy · 2010 · 241 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +17

ACHN-490, a Neoglycoside with Potent In Vitro Activity against Multidrug-Resistant <i>Klebsiella pneumoniae</i> Isolates

Andrea Endimiani, Kristine M. Hujer, Andrea M. Hujer et al. · Antimicrobial Agents and Chemotherapy · 2009 · 116 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Total Synthesis of the Serine-Threonine Phosphatase Inhibitor Microcystin-LA

John M. Humphrey, James B. Aggen, A. Richard Chamberlin · Journal of the American Chemical Society · 1996 · 96 citations

Life Sciences, Biochemistry, Pharmacology +13

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

Bianca J. Lee, Jacob A. Boyer, G. Leslie Burnett et al. · Nature Chemical Biology · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 21